Skip to main content
. 2017 Mar 13;2:6. doi: 10.1038/s41525-017-0007-6

Table 1.

Overall cytosine modification levels of all CpG sites (n = 2.7 × 107) in a glioblastoma patient

Sample % 5mC % 5hmC
Margin 52.1 17.5
Tumour 63.5 1.6